CSPG4 and neoplasm: Tumor cell viability was reduced in melanoma cell lines with high CSPG4 expression (A375, A2058) when treated with anti-CSPG4-(PDD), whereas a lower reduction in cell viability could be observed in the CSPG4-low WM-1361 cell line.